M
Medigate
Medigate owns and operates a medical device security platform that protects all connected medical devices on health care provider networks
About Medigate
Medigate is a cybersecurity company specializing in securing medical devices for healthcare providers. Operating in the Internet of Medical Things (IoMT) market, Medigate offers solutions that provide real-time visibility and security for connected medical devices. The company serves healthcare institutions, ensuring that their IoT devices are securely connected to their networks. Medigate's business model revolves around offering subscription-based cybersecurity services, which include device monitoring, threat detection, and risk management. Revenue is generated through these subscription fees, as well as through strategic partnerships with other healthcare technology providers. The company has been recognized by industry analysts and has formed key partnerships to expand its offerings and enhance its market presence.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2017
- Headquarters
- New York City, United States
- Employees
- 120
- Open positions
- None listed
- Dealroom signal
- 61.6/100
- Industry
- Health, Security
- Sub-industry
- Health Platform, Public safety
- Sector
- Health Tech & Medtech, Network Security, Health Diagnostics, Cybersecurity, Hospital Logistics, Tech for Hospitals and Clinics, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2c
Latest news
Press, funding announcements and product moves mentioning Medigate.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Dec 2021 | $400M | $400M | Claroty | ↗ |
| SERIES BOther financing | Sep 2020 | $30M | $120M | Partech · Blumberg Capital · YL Ventures · U.S. Venture Partners | — |
Growth signals
Latest recorded traffic for Medigate is 11K monthly website visits, up 214.3% over the last three months. Medigate's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Series A3 investors entered at this stage
U.S. Venture Partners
Partech
Maor Investments
Other known investors1 additional known investor
Claroty
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Medigate on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Medigate’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.